Abstract
The RCPAQAP provides a Liquid Serum Chemistry Program sourced from consenting male and female haemochromatosis patients presenting for therapeutic venesection. Where possible, serum from individual male and female patients are pooled over successive collections. The option to report PSA and Free PSA was introduced in the 2022 program. Here we report on the performance at low PSA levels across 6 instruments from 4 vendors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
